PDCD1 and neoplasm: However, tumor cells exploit this process by expressing ligands for these receptors, for example programmed death-ligand 1 (PD-L1 or B7-H1) to bind PD-1, in order to cause T cell exhaustion, which results in T cell inactivation and reduced effector function (21).